ISPUB.com / IJS/9/2/12905
  • Author/Editor Login
  • Registration
  • Facebook
  • Google Plus

ISPUB.com

Internet
Scientific
Publications

  • Home
  • Journals
  • Latest Articles
  • Disclaimers
  • Article Submissions
  • Contact
  • Help
  • The Internet Journal of Surgery
  • Volume 9
  • Number 2

Original Article

Synchronous Colonic Carcinomas

A Hussain, H Mahmood, T Hennigan

Keywords

colorectal cancer crc, metachronous colonic cancer mcc, scc, subtotal colectomy stc, synchronous colonic cancer scc, total colectomy tc

Citation

A Hussain, H Mahmood, T Hennigan. Synchronous Colonic Carcinomas. The Internet Journal of Surgery. 2006 Volume 9 Number 2.

Abstract

A 81 year old man presented with a 3 months history of change in the bowel habit in form of alternating diarrhoea with constipation, significant weight loss over the last 6 months, and generalized fatigability.


Laparotomy confirmed three cancers in the caecum, splenic flexure and rectosigmiod junction for which proctocolectomy and terminal ileostomy performed.

 

Case report

A 81 year old man presented with a 3 months history of change in the bowel habit in form of alternating diarrhoea with constipation, significant weight loss over the last 6 months, and generalized fatigability.

Clinical examination revealed anaemia with non tender soft abdomen, left upper abdominal mass detected but no definite right or left iliac fossa mass and no organomegaly.

Blood tests showed haemoglobin of 10.4 gm/dl white cell count of: 7.4 X 109

Mean cell volume of 80 fl, and mean cell haemoglobin concentration of 25.4 pg

Urea & electrolytes were normal, and total protein was 59gm/L

Radiological examination

Chest x-ray, and plain abdominal x-ray showed no exciting features, while the

CT scan confirmed synchronous colonic tumours in the upper rectum and splenic flexure and the reporting radiologist failed to detect the ceacal carcinoma. Preoperative Colonoscopy not performed.

Laparotomy confirmed three cancers in the caecum, splenic flexure and rectosigmiod junction for which proctocolectomy and terminal ileostomy performed.

Histopathology

1. Ceacal tumour (4x4.5) cm confined to the ceacal wall
Grading :> 50% mucinous, sparse lymphocytic reaction
PT3 beyond muscularis propria.no lymph node metastasis
T3 N0, Dukes B

2. Transverse colon :( 9 x 5.5) cm
Poor differentiation, T3NO, Dukes B

3. Rectosigmiod junction: (6 x 3) cm Penetrates peritoneum with tumour cells on the surface.PT4 N1

The patient did very well after surgery and he received Chemotherapy postoperatively.

Checking CT scan one year after operation reported as normal. The patient was well with no signs of recurrence 32 months after the operation.

Figure 1
Figure 1: preoperative plain abdomen

Figure 2
Figure 2: preoperative chest x-ray showed a pacemaker on the left side

Figure 3
Figure 3: CT scan showed ceacal tumour

Figure 4
Figure 4: CT showed splenic flexure tumour

Figure 5
Figure 5: upper rectal tumour

Discussion

Colonic carcinoma reported to be increasingly diagnosed in all developed countries (1), in England &Wales more than 30.000 newly diagnosed and between the ages of 45 and 55, the incidence is about 25 per 100,000. Among those aged 75 and above, however, the rate is more than 10 times this: over 300 per 100,000 per year, while in USA Colorectal cancer (CRC) is the second most common cancer, primarily a disease of elderly (138,000 new cases / year) (2,3). Women generally more liable to have cc.

In general, the risk of developing cancer increases with ageing (4, 5).The median age of patients at diagnosis is over 70 year (6)

It appears that survival rates were poorer in the UK than in Europe as a whole (7, 8) and five-year survival rate was 43%, but there was a marked north-south gradient (9).

It has been shown that patients in the age group of 65–74 were 1.8 times more likely to die following surgery compared with 3.5 times for 75 to 84 years and 5 times for over 85 years. These elderly cases with CRC are still presenting as surgical emergencies (obstruction and/or perforation) in up to 40% of cases, of which a small percent will represent synchronous or metachronous cc which is reported more frequently in patient after 8-10 years of first operation.

Although the reports on the frequency of multiple carcinomas of the colon and rectum have varied from 1-5% (10,11), patients with a first tumour located within the proximal colon are at twice the risk for developing metachronous colorectal cancer (12)and the distribution of second tumours showed a significant shift from the distal to the proximal site (13).

It is likely that tiny lesions, which were still in the adenoma phase, were not diagnosed by the endoscopy; it is also possible that the adenoma-carcinoma sequence was extremely fast. On the basis of this experience some authors recommend that patients with metachronus carcinoma undergo either frequent controls or a preventive subtotal colectomy. (14, 15,16).

Synchronous colonic cancers are closely related with a genetic instability of the colonic mucosa and therefore the total colectomy is a safe manner to prevent metachronous lesions (17). The risk of metachronous carcinoma of the colon and rectum at 40 year follow-up evaluation is as high as 30 percent (18)that's why extensive use of preoperative colonoscopy is recommended in the evaluation of colorectal cancer, in order to promote detection of synchronous tumours, reduce the incidence of 'early metachronous' cancer and avoid malignant degeneration of adenomatous polyp.

Diagnosis

There is evidence that the rate of mortality from colorectal cancer can be reduced by screening asymptomatic persons at average risk, beginning at the age of 50 years. (19, 20, 21, 22, 23). Serrated adenomas are the precursors of at least 5.8% of colorectal cancers (24).

The distribution of synchronous malignancies showed a significant shift from the proximal to the distal site, while in metachronous malignancies, the distribution of second tumours showed a significant shift from the distal to the proximal site (25).

Many authors stressed the importance of preoperative pan colonoscopy for the identification of possible synchronous tumours (both benign and malignant) and long-lasting endoscopic follow-up for the detection of recurrent or metachronous lesions especially hereditary nonpolyposis colorectal carcinoma (HNPCC) (4, 26, 27)

After diagnosis, patients should be assessed for suitability for surgery, that's to be decided at multidisciplinary team meeting in addition to the proposal of other form of adjuvant therapy. Pelvic MRI &and TRUS (transrectal ultrasound) will be performed to provide the most reliable information about both the

involvement of adjacent structures and of pelvic wall lymph node metastasis.

(28).In patients with known colorectal cancer, preoperative investigation is unreliable for the detection of all synchronous neoplasia and those patients should have postoperative colonoscopy (29)

Treatment

In general, first line of treatment for colorectal cancer is surgery.

Synchronous colonic cancers pose a question of what is the best way of treatment. Majority of authors recommended more aggressive approach in dealing with synchronous carcinoma.

Total mesorectal excision (TME) has become a new standard of operative treatment for rectal cancer replacing conventional receptions (30) also taken in consideration when dealing with synchronous cancerous lesion. The emergency surgery is associated with a significantly higher incidence of operative mortality at any age (15% on emergency Vs 5% Elective surgery (4,31). According to the guidelines (28) the surgeons should aim to achieve an operative mortality of less than 20% for emergency surgery and 5% for elective surgery for colorectal cancer and to achieve an overall clinical leak rate below 8% for anterior resection and below 4% for other types of resection

The presence of adenomas in a younger patient with a primary carcinoma of the colon and rectum represents a high risk of future carcinoma. Subtotal colectomy should be considered in these patients and may also improve the life-long follow-up evaluation required by allowing proctosigmoidoscopy alone to evaluate effectively the remaining colon and rectum.(10) Its recommend an extensive use of preoperative colonoscopy and a careful intraoperative exploration of the viscera. It is also important that patients undergo periodical postoperative endoscopic controls (32)

In view of the metachronous carcinoma risk after first resection, it seems to be the best way of management is radical resection in form of TC, STC or proctocolectomy depending on the sites of the lesion.

There is no doubt that the presence of known synchronous carcinomas in separate segments of the colon constitutes a clear indication for subtotal colectomy(STC) as the procedure of choice. The combination of a primary malignant tumor and multiple scattered polyps also is a strong indication. (33,34)

Prognosis

Patients with synchronous tumors did not show appreciable differences in survival when compared with individuals who had single neoplasms. In contrast, a poor clinical outcome was observed in patients with metachronous tumors after the development of the second carcinoma (10)

Follow up

As total or subtotal colectomy performed for these patients, therefore the follow up will be by tumour markers, CT scan, PET scan and MRI.

Conclusion

Radical resection in form of total, subtotal colectomy, and Proctocolectomy may be the best choice for synchronous colonic cancer.

Intraoperative meticulous search for a second colonic cancer and the postoperative colonoscopy are important to detect the synchronous cancers and to reduce the incidence of the metachronous lesions.

References

1. Zalit NIu, Prorokov VV, Anan'evVS, Saiavets NN, Zalit IN, Potemkin VA
The incidence and primary multiplicity of colon cancer, Klin Med (Mosk). 2006;84(2):15-9.
2. Wald, A. Large Bowel. In: Raymond T, Hower F, Brocklehurst JC. , editor. Brocklehurst's Textbook of Geriatric Medicine and Gerontology. 5. London: Churchill Livingstone; 1999. pp. 891–895.
3. Seidfeldin R, Hantsch JJ. The economic burden associated with colon cancer in the United states. Clin Ther. 1999;21:1370–1379. doi: 10.1016/S0149-2918(99)80037-X
4. Benfatto G, Catania G, Buffone A, Benfatto SA, Licari V, Tenaglia L, Giovinetto R, Fancello R, Giovinetto A. Metachronous carcinoma of the colon: report of a clinical case] 7.Chirurgia (Bucur). 1: G Chir. 2003 Aug-Sep;24(8-9):285-8.
5. Tekkis, PO.; Poloniecki, JD.; Thompson, MR.; Stamatakis, JD. ACPGBI Colorectal cancer study 2002 – Part A: Unadjusted outcomes. (b) Tekkis PP, Poloniecki JD, Thompson MR, Stamatakais JD: ACPGBI Colorectal study 2002 Part B Risk adjusted outcomes The ACPGBI colorectal Cancer Model.
6. Colorectal Cancer Guidelines DRAFT May 2004, incorporating recommendations from: Royal College of Surgeons and the Association of Coloproctology Guidelines forthe Management of Colorectal Cancer, 2001
The Report on Colorectal Cancer Services for Residents of Gloucestershire
prepared by the Colorectal Cancer Sub-Group for the County-wide Cancer
Strategy Group, August 1997. Guidance on Commissioning Cancer Services: Improving Outcomes in Colorectal Cancer, November 1997
7. Berrino F, Sant M, Verdecchia A, et al (eds). Survival of Cancer Patients in Europe: the Eurocare Study. IARC Scientific Publications No. 132. Lyon: International Agency for Research on Cancer, 1995.
8. Berrino F, Capocaccia R, Esteve J, et al (eds). Survival of Cancer Patients in Europe: the Eurocare-2 Study. IARC Scientific Publication No. 151. Lyon: International Agency for Research on Cancer, 1999.
9. 12 Office for National Statistics. Cancer survival in the health authorities of England, 1993-2000. Health Statistics Quarterly 2002;13:95-104.
10. Fante R, Roncucci L, Di GregorioC, Tamassia MG, Losi L, Benatti P, Pedroni M, Percesepe A, De Pietri S, Ponz de Leon M. Frequency and clinical features of multiple tumors of the large bowel in the general population and in patients with hereditary colorectal carcinomaCancer. 1996 May 15;77(10):2013-21
11. Luchtefeld MA, Ross DS, Zander JD, Folse JR. Late development of metachronous colorectal cancer. Dis Colon Rectum. 1987 Mar;30(3):180-4.
12. Gervaz P, Bucher P, Neyroud-Caspar I, Soravia C, Morel P. Proximal location of colon cancer is a risk factor for development of metachronous colorectal cancer: a population-based study. Dis Colon Rectum. 2005 Feb;48(2):227-32.
13. Ikeda Y, Saku M, Kawanaka H, Muranaka T, Takeshita M, Watanabe J,. Yoshida K, Sugimachi K. Distribution of synchronous and metachronous multiple colorectal cancers. Hepatogastroenterology. 2004 Mar-Apr;51(56):443-6.
14. Gosney, M. Geriatric Oncology: In: Raymond T, Howard F, Brocklehurst JC. , editor. Brocklehurst's Textbook of Geriatric Medicine and Gerontology. 5. London: Churchill Livingstone; 1999. pp. 1319–1328.
15. Benfatto G, Catania G, Buffone A, Benfatto SA, Licari V, Tenaglia L, GiovinettoR, Fancello R, Giovinetto A. Metachronous carcinoma of the colon: report of a clinical case, G Chir. 2003 Aug-Sep;24(8-9):285-8.
16. Diaconu C, Dogaru C, Scripcariu V, Stoian M, Dragomir C, Russu I,
Pandrea V, Zugun F, Carasievici E, Mihailovici MS. Synchronous colonic cancers] Chirurgia (Bucur). 2002 Jul-Aug;97(4):351-5.
17. Diaconu C, Dogaru C, Scripcariu V, Stoian M, Dragomir C, Russu I,Pandrea V,Zugun F, Carasievici E, Mihailovici MS, Synchronous colonic cancers, 7.Chirurgia (Bucur). 2002 Jul-Aug;97(4):351-5.
18. Demeter JG, Freeark RJ. The role of prophylactic subtotal colectomy
19. .andel JS, Bond JH, Church TR, et al. Reducing mortality from colorectal cancer by screening for fecal occult blood. N Engl J Med 1993;328:1365-1371. [Erratum, N Engl J Med 1993;329:672.]
20. Hardcastle JD, Chamberlain JO, Robinson MHE, et al. Randomised, controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet 1996;348:1472-1477.
21. Kronberg O, Fenger C, Olsen J, Jorgensen OD, Sondergaard O. Randomised study of screening for colorectal cancer with faecal-occult-blood test. Lancet 1996;348:1467-1471.
22. Selby JV, Friedman GD, Quesenberry CP Jr, Weiss NS. A case-control study of screening sigmoidoscopy and mortality from colorectal cancer. N Engl J Med 1992;326:653-657.
23. Newcomb PA, Norfleet RG, Storer BE, Surawicz TS, Marcus PM. Screening sigmoidoscopy and colorectal cancer mortality. J Natl Cancer Inst 1992;84:1572-1575.
24. Lazarus R, Junttila OE, Karttunen TJ, Makinen MJ. The risk of metachronous neoplasia in patients with serrated adenoma. Am J Clin Pathol. 2005 Mar;123(3):349-59
25. Ikeda Y, Saku M, Kawanaka H, Muranaka T, Takeshita M, Watanabe J, Yoshida K, Sugimachi K ,Distribution of synchronous and metachronous multiple colorectal cancers, Hepatogastroenterology. 2004 Mar-Apr;51(56):443-6.
26. La Ganga V, Cavanna A, Di Ponzio D, Montobbio A. [Synchronous carcinoma of the colon and rectum , Minerva Chir. 1995 Dec;50(12):1069-72
27. AH Mosca F, Stracqualursi A, Latteri F, Palazzo F, Vecchio R, Di Franco F,
Consoli A. [Synchronous primary carcinoma of the colon. Diagnostic and therapeutic problems] G Chir. 1998 Aug-Sep;19(8-9):347-50.
28. Quinn M, Babb P, Brock A, Kirby L, Jones J. Cancer trends in England and Wales 1950-1999. London: The Stationery Office, 2001.
29. Tate JJ, Rawlinson J, Royle GT, Brunton FJ, Taylor I. Pre-operative or postoperative colonic examination for synchronous lesions in colorectal cancer. Br J Surg. 1988 Oct;75(10):1016-8.
30. Kapiteijn E, Van de Velde CJ. The role of total mesorectal excision in the management of rectal cancer. Surg Clin North Am. 2002;82:995–1007.
Aurello P, Fegiz G. Effect of preoperative colonoscopy on the incidence of synchronous and metachronous neoplasms. 8. Acta Chir Scand. 1990 Feb;156(2):163-6.
31. Audisio RA, Veronesi P, Ferrario L, Cipolla C, Andreoni B, Aapro MS. Elective Surgery for gastrointestinal tumours in the elderly. Ann Oncol. 1997;8:317–326. doi: 10.1023/A:1008294921269.
32. La Ganga V, Cavanna A, Di Ponzio D, Montobbio A. Synchronous carcinoma of the colon and rectum] Minerva Chir. 1995 Dec;50(12):1069-72
33. D K Brief, B J Brener, R Goldenkranz, J Alpert, V Parsonnet, R Ferrante, J Huston, and D Eisenbud, Defining the role of subtotal colectomy in the treatment of carcinoma of the colon.
Ann Surg. 1991 March; 213(3): 248–252.
34. Giglio D, Di Muria A, Marano A, Cione G, Arciero G, Rossi R, Aveta M, Formisano V[Urgent management of obstructing colo-rectal cancer: authors' experience] Ann Ital Chir. 2004 Jan-Feb;75(1):35-9; discussion 39

Author Information

A. Hussain, FRCS, FICS, Dip (General surgery)
Senior Clinical Fellow, Princess Royal University Hospital

H. Mahmood, MB, ChB
Princess Royal University Hospital

T. Hennigan, FRCS
Consultant surgeon, Princess Royal University Hospital

Download PDF

Your free access to ISPUB is funded by the following advertisements:

 

BACK TO TOP
  • Facebook
  • Google Plus

© 2013 Internet Scientific Publications, LLC. All rights reserved.    UBM Medica Network Privacy Policy